Letter: PCSK9 inhibitor for liver transplant patients during the post-statin era? Authors' reply.

Becchetti, Chiara; Dirchwolf, Melisa; Berzigotti, Annalisa; Bosch, Jaume (2023). Letter: PCSK9 inhibitor for liver transplant patients during the post-statin era? Authors' reply. Alimentary pharmacology & therapeutics, 57(1), pp. 187-188. Wiley-Blackwell 10.1111/apt.17295

[img] Text
Aliment_Pharmacol_Ther_-_2022_-_Becchetti_-_Letter_PCSK9_inhibitor_for_liver_transplant_patients_during_the_post_statin.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Download (213kB)

Item Type:

 Journal Article (Further Contribution)

Division/Institute:

 04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie

UniBE Contributor:

 Becchetti, Chiara, Berzigotti, Annalisa, Bosch Genover, Jaime

Subjects:

 600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

 0269-2813

Publisher:

 Wiley-Blackwell

Language:

 English

Submitter:

 Pubmed Import

Date Deposited:

 12 Dec 2022 10:02

Last Modified:

 06 Mar 2024 16:33

Publisher DOI:

 10.1111/apt.17295

PubMed ID:

 36480715

BORIS DOI:

 10.48350/175650

URI:

 https://boris.unibe.ch/id/eprint/175650

Actions (login required)

Edit item Edit item
Provide Feedback